丹参酮ⅡA磺酸钠注射液改善脂多糖-高糖腹膜透析液诱导的人腹膜间皮细胞损伤的实验研究

周瑶; 高坤; 夏平; 李蔚; 周占威; 孙敏捷; 孙伟; 王立军; 何伟明

丹参酮ⅡA磺酸钠注射液改善脂多糖-高糖腹膜透析液诱导的人腹膜间皮细胞损伤的实验研究

周瑶¹,
高坤²,
夏平¹,
李蔚¹,
周占威³,
孙敏捷³,
孙伟²,
王立军^4,,
何伟明^2,

1.
南京中医药大学第一临床医学院，江苏南京 210023
2.
南京中医药大学附属医院，江苏南京 210029
3.
中国药科大学药学院，江苏南京 210011
4.
中国中医科学院广安门医院，北京 100055

计量
- 文章访问数: 987
- HTML全文浏览量: 3
- PDF下载量: 968
- 被引次数: 0
出版历程
- 刊出日期: 2017-11-10

Sulfotanshinone ⅡA Sodium Ameliorates Lipopolysaccharide-Peritoneal Dialysis Solution-Elicited Human Peritoneal Mesothelial Cells Injury

1.
The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210029, China
2.
Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China
3.
School of Pharmacy, China Pharmaceutical University, Nanjing, 210011, China
4.
Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100055, China

摘要

摘要: 目的评估丹参酮ⅡA磺酸钠注射液（STS）减轻脂多糖-高糖腹膜透析液（LPS-PDS）诱导的人腹膜间皮细胞（HPMCs）损伤以及抑制腹膜纤维化的作用。方法 HPMCs来自腹腔外科手术患者腹膜细胞的原代培养。以LPS-PDS诱导的HPMCs损伤为模型，通过观察STS对HPMCs增殖活性、转化生长因子-β（TGF-β1）分泌、基质金属蛋白酶-9（MMP-9）、组织基质金属蛋白酶抑制因子-1（TIMP1）等的影响，阐明STS对HPMCs的保护作用及抗腹膜纤维化的机理。结果 LPS-PDS可造成HPMCs损伤，表现为活性下降，STS可明显减轻LPS-PDS对HPMCs的毒性，改善其造成的细胞活性下降，减轻LPS-PDS诱导的TGF-β1、TIMP1 mRNA上调和MMP-9 mRNA表达下降。结论 STS可以减轻LPS-PDS诱导的HPMCs损伤，可能是通过调节TGF-β1、TIMP1、MMP-9等蛋白的表达，发挥保护腹膜细胞和拮抗腹膜纤维化的作用。
- 腹膜透析 /
- 人腹膜间皮细胞 /
- 原代培养 /
- 丹参酮ⅡA磺酸钠注射液 /
- 腹膜纤维化
Abstract: OBJECTIVE To study the effect and mechanism of sulfotanshinone ⅡA sodium (STS) in human peritoneal mesothelial cells (HPMCs) injury and peritoneal fibrosis caused by lipopolysaccharide-peritoneal dialysis solution (LPS-PDS). METHODS HPMCs was primary cultured from patients undergoing peritoneal surgery. The cells were incubated with LPS-PDS to mimic the peritoneal dialysis conditions in vitro. After treatment of cells with STS， cellular viability was tested and mRNA were collected and subjected to RT-PCR to evaluated the level of TGF-β1， TIMP-1 and MMP-9. RESULTS Incubation HPMCs with LPS-PDS elicited cell injury. STS attenuated LPS-PDS-induced cell injury by improvement of cellular viability. Furthermore， STS inhibited HPMCs fibrosis as evidenced by suppression of TGF-β1 and TIMP1 induced by LPS-PDS and increasing MMP-9 mRNA level. CONCLUSION STS protects HPMCs against LPS-PDS-induced cell injury. Moreover， STS retards HPMCs fibrosis by decreasing TGF-β1 and TIMP1 mRNA level and increasing MMP-9 mRNA.
- peritoneal dialysis /
- human peritoneummesothelial cells /
- primary cell cultured /
- sulfotanshinone ⅡA sodium injection /
- peritoneal fibrosis

HTML全文

参考文献(14)

[1]	POON PY， LAN HY， KWAN BC， et al. Peritoneal inflammation and fibrosis in C-reactive protein transgenic mice undergoing peritoneal dialysis solution treatment[J]. Nephrology (Carlton)， 2017， 22(2): 125-132.
[2]	石永兵，金东华，詹周兵，等．人腹膜间皮细胞的原代培养及传代[J]．苏州大学学报(医学版)，2010， 30（2）：307-309．
[3]	SHI YB， JIN DH， ZHAN ZB， et al. Primary culture and passage of human peritoneal mesothelialcells[J]. Suzhou Univ J： Med Sci， 2010， 30(2): 307-309.
[4]	YOSHIZAWA H， MORISHITA Y， WATANABE M， et al. TGF-β-siRNA delivery with nanoparticles inhibits peritoneal fibrosis[J]. Gene Ther， 2015， 22(4): 333-340.
[5]	ZHANG L， LI Z， HE W， et al. Effects of astragaloside Ⅳ against the TGF-β1-induced epithelial-to-mesenchymal transition in peritoneal mesothelial cells by promoting Smad 7 expression[J]. Cell Physiol Biochem， 2015， 37(1): 43-54.
[6]	孟立锋，向彩春，杨端云，等. 加味六君子汤对腹膜纤维化大鼠TGF-β/Smad信号通路的影响[J]. 中医临床研究， 2016， 8(12):18-20.
[7]	MENG LF， XIANG CC， YANG DY， et al. Effect of modified Liujunzi decoction on TGF-β/Smad signal pathway of peritoneal fibrosis rat model[J]. Clin J Chin Med，2016， 8(12):18-20.
[8]	刘小贤，汪卫，王圳，等．转化生长因子-β1对大鼠腹膜间皮细胞炎症因子及细胞外基质表达的影响[J]．浙江医学，2015， 37（4）：273-277．
[9]	LIU XX， WANG W， WANG Z， et al. TGF-β1 induces up-regulation of inflammatory factors and accumulation of extracellular matrix in rat peritoneal mesothelial cells[J]. Zhejiang Med J， 2015， 37(4): 273-277.
[10]	HA H， LEE HB. Effect of high glucose on peritoneal mesothelial cell biology[J]. Perit Dial Int， 2000， 20(Suppl 2): S15-S18.
[11]	刘伏友，段绍斌，龙志高，等. 人腹膜间皮细胞的培养和特点[J]. 湖南医科大学学报， 2001， 26(4): 321-324.
[12]	LIU FY， DUAN SB， LONG ZG， et al. The culture and characteristics of peritoneal skin cells[J]. Bull Hunan Med Univ，2001， 26(4): 321-324.
[13]	QU H， LI J， WU LD， et al. Trichostatin A increases the TIMP-1/MMP ratio to protect against osteoarthritis in an animal model of the disease[J]. Mol Med Rep， 2016， 14(3): 2423.
[14]	YANG CY， CHAU YP， CHEN A， et al. Targeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis[J]. World J Nephrol， 2017， 6(3): 111-118.